The blood-brain barrier and immune function and dysfunction.
about
Immune responses at brain barriers and implications for brain development and neurological function in later lifeLinking Activation of Microglia and Peripheral Monocytic Cells to the Pathophysiology of Psychiatric DisordersEarly life programming of pain: focus on neuroimmune to endocrine communicationNeuroimmune Function and the Consequences of Alcohol ExposureGut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune DysregulationPhysiology and pathophysiology of the blood-brain barrier: P-glycoprotein and occludin trafficking as therapeutic targets to optimize central nervous system drug deliveryCytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaiseChemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapyEnvironment, dysbiosis, immunity and sex-specific susceptibility: a translational hypothesis for regressive autism pathogenesisAutonomic nervous system and immune system interactionsAndrographolide attenuates LPS-stimulated up-regulation of C-C and C-X-C motif chemokines in rodent cortex and primary astrocytesSphingosine kinase 1 deficiency exacerbates LPS-induced neuroinflammationEndotoxemia-mediated inflammation potentiates aminoglycoside-induced ototoxicity.Balancing the immune response in the brain: IL-10 and its regulationPsychobiotics and the Manipulation of Bacteria-Gut-Brain SignalsMechanisms of neuroimmune gene induction in alcoholismLupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosusMaintaining brain health by monitoring inflammatory processes: a mechanism to promote successful aging'Multimorbidity' as the manifestation of network disturbances.Autoimmune manifestations in the 3xTg-AD model of Alzheimer's disease.Cellular and molecular mechanisms of immunomodulation in the brain through environmental enrichment.The immune system and developmental programming of brain and behavior.Cytokine and chemokine responses in serum and brain after single and repeated injections of lipopolysaccharide: multiplex quantification with path analysis.Inflammation-induced dysfunction of the low-density lipoprotein receptor-related protein-1 at the blood-brain barrier: protection by the antioxidant N-acetylcysteine.Vibrio vulnificus MO6-24/O lipopolysaccharide stimulates superoxide anion, thromboxane B₂, matrix metalloproteinase-9, cytokine and chemokine release by rat brain microglia in vitro.A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkersPlexin-A1 is required for Toll-like receptor-mediated microglial activation in the development of lipopolysaccharide-induced encephalopathyToll-like receptor signaling and stages of addiction.Are the Gut Bacteria Telling Us to Eat or Not to Eat? Reviewing the Role of Gut Microbiota in the Etiology, Disease Progression and Treatment of Eating Disorders.Systemic injection of low-dose lipopolysaccharide fails to break down the blood-brain barrier or activate the TLR4-MyD88 pathway in neonatal rat brain.Vascular disruption and blood-brain barrier dysfunction in intracerebral hemorrhage.Acute lipopolysaccharide exposure facilitates epileptiform activity via enhanced excitatory synaptic transmission and neuronal excitability in vitro.Peripheral inflammation acutely impairs human spatial memory via actions on medial temporal lobe glucose metabolismLinking cardiometabolic disorders to sporadic Alzheimer's disease: a perspective on potential mechanisms and mediators.The immune response in glaucoma: a perspective on the roles of oxidative stressHuman sickness behavior: Ultimate and proximate explanations.Molecular and cellular neuroinflammatory status of mouse brain after systemic lipopolysaccharide challenge: importance of CCR2/CCL2 signaling.Biphasic modulation of paracellular claudin-5 expression in mouse brain endothelial cells is mediated through the phosphoinositide-3-kinase/AKT pathwayThe cytokine response to human traumatic brain injury: temporal profiles and evidence for cerebral parenchymal production.Moving towards a cure: blocking pathogenic antibodies in systemic lupus erythematosus.
P2860
Q21558388-155DB3DB-8835-48E9-9F4D-DF4F6E87A709Q26745417-897DA2EB-204C-4E1B-BC79-3387297C6AFDQ26751421-389BEFE1-AEED-475F-8D38-E8E9BA3403A6Q26773207-AC379267-D6D0-4A47-9072-133D1EA9D9F0Q26824638-EFE0BCC1-B383-49C7-A1B9-220F0B5D2327Q26861408-E4944379-9264-4AD3-AD4F-B7F403D1B32EQ27001628-075E7D06-FC12-4B8F-ABDB-321899D4BEA3Q27011451-87928E4E-BDBE-4FFD-A8E9-3E0266010DD8Q27024805-12A112B5-337D-41F9-8EAE-1337A19D1331Q27026889-1CEF4C28-73A1-44C6-9358-8488404AE148Q27303312-D481C1DB-9D2E-4CAD-ABB5-067B437BBBCDQ27303619-8C20AB42-BECB-46E9-8E25-300E5ED2F314Q27324803-7213EB87-F8A4-4BC0-AAE6-42C9E8B9D0A9Q28073951-5EF8A896-5223-429B-955F-DA4019CE617EQ28078842-9892C9CB-167B-4921-B3D0-320823935224Q28085043-DD021D09-4DC8-4B11-8F01-86F98CCD9E01Q28268802-D077DDF0-DFAA-40E1-871C-539702C056B5Q28730725-818CE8DB-B170-4674-BF55-878FCBEFC39CQ30390588-84BEA5A3-A9A2-44A9-B1FB-AC60DD01DAAEQ30415876-C6C371D4-856B-4721-BFD6-2CB66F130990Q30439617-5563E3AC-4156-447E-B302-E7621C30A878Q30449556-0EDFCBB3-9D1E-40A5-9BF4-3A86F8247340Q30519502-8105C445-8C8F-4D68-AE63-9EE268ECCA58Q30524688-ACFF727B-8866-45EC-BDD4-98BE464C6194Q33575716-F5E88A4E-8B8D-4F66-9F9D-84C5EFAA721EQ33587452-52C33EA2-2C93-4081-A1CD-868A556DE4D4Q33608671-108B2244-A7EA-4B03-8D02-1841BD7D4000Q33645274-AE8BD93B-AEBA-4858-B8F0-20367BDAA388Q33852050-0B8B098B-717A-4C37-A364-BE7DB7A282E8Q33907683-EA739D3E-912E-47DE-A5DD-272EC6A343EBQ34033129-C16A3DD4-688B-4C09-B9B4-282F34E3E53FQ34090045-EFCE541A-2B2E-4B20-9704-67E333FDAB6DQ34199733-04E0F259-69D6-494F-AF50-756B7845F1B6Q34268223-7EDD24BD-036D-4047-BE78-D75DD403699AQ34388254-6D32B8D6-3D42-4747-99B2-5E49A46996F9Q34460763-D2D4366D-7DE0-4237-AFE7-124DD33981C8Q34544873-FCA299B4-EC6B-437E-A921-D30C5177AC59Q34573889-9414A6D8-997E-492B-9537-86B4C070CC58Q34627631-341CC0DC-B727-4912-A139-CD4C749BEAD9Q34753885-40D7E3A4-CD94-4556-8641-AE134A686E3B
P2860
The blood-brain barrier and immune function and dysfunction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The blood-brain barrier and immune function and dysfunction.
@en
The blood-brain barrier and immune function and dysfunction.
@nl
type
label
The blood-brain barrier and immune function and dysfunction.
@en
The blood-brain barrier and immune function and dysfunction.
@nl
prefLabel
The blood-brain barrier and immune function and dysfunction.
@en
The blood-brain barrier and immune function and dysfunction.
@nl
P1476
The blood-brain barrier and immune function and dysfunction.
@en
P2093
Michelle A Erickson
P356
10.1016/J.NBD.2009.07.031
P577
2009-08-05T00:00:00Z